Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Follow-up of Infacort in Neonates, Infants and Children With Congenital Adrenal Hyperplasia and Adrenal Insufficiency
NCT02733367Phase 3Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Mar 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in adrenal insufficiency (AI), congenital adrenal hyperplasia (CAH), sponsored by Neurocrine Biosciences. Started Mar 2016; status: completed.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on NCT02733367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733367.